Quanterix

Quanterix company information, Employees & Contact Information

Explore related pages

Related company profiles:

Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts.

Company Details

Employees
624
Founded
-
Address
900 Middlesex Tpke, Billerica,massachusetts 01821,united States
Phone
617-301-9400
Email
in****@****rix.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Billerica, Massachusetts
Looking for a particular Quanterix employee's phone or email?

Quanterix Questions

News

Quanterix Expands Reach with IVD and Large Reference Labs - Business Wire

Quanterix Expands Reach with IVD and Large Reference Labs Business Wire

Breakthrough: Quanterix Unveils Revolutionary Blood Tests for Early Alzheimer's Detection - Stock Titan

Breakthrough: Quanterix Unveils Revolutionary Blood Tests for Early Alzheimer's Detection Stock Titan

How innovation in dried blood spot testing is transforming neurological disease monitoring - News-Medical

How innovation in dried blood spot testing is transforming neurological disease monitoring News-Medical

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION - Yahoo Finance

Quanterix Expands Capabilities with Strategic Acquisition of EMISSION Yahoo Finance

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit - Business Wire

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit Business Wire

Quanterix Strikes Deal with Activist Investor: New Board Member, Major Governance Changes Coming - Stock Titan

Quanterix Strikes Deal with Activist Investor: New Board Member, Major Governance Changes Coming Stock Titan

Biomarker Detection Leader Quanterix to Share Growth Strategy at Major Canaccord Conference - Stock Titan

Biomarker Detection Leader Quanterix to Share Growth Strategy at Major Canaccord Conference Stock Titan

Quanterix - SelectScience

Quanterix SelectScience

Quanterix Appoints Ivana Magovčević-Liebisch to Board of Directors - citybiz

Quanterix Appoints Ivana Magovčević-Liebisch to Board of Directors citybiz

Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection - Neurology® Journals

Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection Neurology® Journals

Improving the Accuracy, Robustness, and Dynamic Range of Digital Bead Assays - ACS Publications

Improving the Accuracy, Robustness, and Dynamic Range of Digital Bead Assays ACS Publications

Quanterix Acquires Akoya, Expands Biomarker Detection Market to $5B | QTRX Stock News - Stock Titan

Quanterix Acquires Akoya, Expands Biomarker Detection Market to $5B | QTRX Stock News Stock Titan

Quanterix Appoints Vandana Sriram as Chief Financial Officer - citybiz

Quanterix Appoints Vandana Sriram as Chief Financial Officer citybiz

Akoya Biosciences Reports First Quarter 2025 Financial Results - Yahoo Finance

Akoya Biosciences Reports First Quarter 2025 Financial Results Yahoo Finance

Exploring bead-based immunoassay platforms - News-Medical

Exploring bead-based immunoassay platforms News-Medical

Quanterix’s First Quarter 2023 Earnings Conference Call - Business Wire

Quanterix’s First Quarter 2023 Earnings Conference Call Business Wire

William Donnelly Appointed to Quanterix’s Board of Directors - citybiz

William Donnelly Appointed to Quanterix’s Board of Directors citybiz

Neurofilament light: An established neuronal injury biomarker - News-Medical

Neurofilament light: An established neuronal injury biomarker News-Medical

Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test - Business Wire

Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test Business Wire

Quanterix Releases Operating Results for First Quarter 2023 - Business Wire

Quanterix Releases Operating Results for First Quarter 2023 Business Wire

Quanterix Appoints Masoud Toloue CEO - citybiz

Quanterix Appoints Masoud Toloue CEO citybiz

Quanterix Appoints Shawn Stetson as Chief Financial Officer - citybiz

Quanterix Appoints Shawn Stetson as Chief Financial Officer citybiz

The exploration of using plasma biomarkers of p-tau217 and p-tau181 for screening Alzheimer’s disease in very elderly people - Frontiers

The exploration of using plasma biomarkers of p-tau217 and p-tau181 for screening Alzheimer’s disease in very elderly people Frontiers

Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology - Seeking Alpha

Quanterix: Advancing sNfL Reference Ranges In Pediatric Neurology Seeking Alpha

Quanterix Corporation Releases Operating Results for Third Quarter 2022 - The Globe and Mail

Quanterix Corporation Releases Operating Results for Third Quarter 2022 The Globe and Mail

Improving Alzheimer Diagnosis With Innovative Blood-Based Biomarker Tests and BD-Tau: Mike Miller, PhD - NeurologyLive

Improving Alzheimer Diagnosis With Innovative Blood-Based Biomarker Tests and BD-Tau: Mike Miller, PhD NeurologyLive

Quanterix: Hard To Make A Good Diagnosis (NASDAQ:QTRX) - Seeking Alpha

Quanterix: Hard To Make A Good Diagnosis (NASDAQ:QTRX) Seeking Alpha

Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology - Frontiers

Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology Frontiers

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results GlobeNewswire

Quanterix (QTRX) Stock: Still Many, Many Questions - Seeking Alpha

Quanterix (QTRX) Stock: Still Many, Many Questions Seeking Alpha

FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease - Psychiatric Times

FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease Psychiatric Times

FDA Grants Breakthrough Device Designation to Simoa Neurofilament Light Chain Test for Multiple Sclerosis - NeurologyLive

FDA Grants Breakthrough Device Designation to Simoa Neurofilament Light Chain Test for Multiple Sclerosis NeurologyLive

Quanterix launches prescription blood test for Alzheimer's disease - Fierce Biotech

Quanterix launches prescription blood test for Alzheimer's disease Fierce Biotech

Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood-onset dementia - Wiley Online Library

Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood-onset dementia Wiley Online Library

Quanterix Launches High-Sensitivity Benchtop Instrument and Assays for Multiplex Biomarker Detection - Lab Manager

Quanterix Launches High-Sensitivity Benchtop Instrument and Assays for Multiplex Biomarker Detection Lab Manager

Helping Solve the CTE Conundrum - Genetic Engineering and Biotechnology News

Helping Solve the CTE Conundrum Genetic Engineering and Biotechnology News

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia - Neurology® Journals

Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia Neurology® Journals

N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection - Nature

N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Nature

Examining Inflammatory Cytokines in Serum and Plasma - Genetic Engineering and Biotechnology News

Examining Inflammatory Cytokines in Serum and Plasma Genetic Engineering and Biotechnology News

QTRX Stock Price and Chart — NASDAQ:QTRX - TradingView

QTRX Stock Price and Chart — NASDAQ:QTRX TradingView

Single-Protein Biomarker Detection - Genetic Engineering and Biotechnology News

Single-Protein Biomarker Detection Genetic Engineering and Biotechnology News

Quanterix to Discuss Precision Cardiovascular Medicine at World Medical Innovation Forum - MarketScreener

Quanterix to Discuss Precision Cardiovascular Medicine at World Medical Innovation Forum MarketScreener

Top Quanterix Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant